Gang Xiao, Jiaoyang Ning, Su Wen, Liu Chen, Hao Wen, Keqin Zhang, Jie Yang, Qi Wu, Jing Zhang, Guilong Tanzhu, Min Su, Haibin Deng, Rongrong Zhou
{"title":"Molecular subtyping of brain metastasis-related genes in lung adenocarcinoma via scRNA-seq and bulk RNA-seq integration: A focus on TPX2.","authors":"Gang Xiao, Jiaoyang Ning, Su Wen, Liu Chen, Hao Wen, Keqin Zhang, Jie Yang, Qi Wu, Jing Zhang, Guilong Tanzhu, Min Su, Haibin Deng, Rongrong Zhou","doi":"10.21147/j.issn.1000-9604.2026.05.08","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Brain metastasis (BrM) is a common complication of advanced lung cancer with extremely poor prognosis. This study aimed to establish a molecular classification system for stratifying non-small cell lung cancer (NSCLC)-BrM patients and predicting survival, and to identify key BrM-related molecules and elucidate their mechanisms as potential therapeutic targets.</p><p><strong>Methods: </strong>We integrated single-cell and bulk transcriptomic data to construct molecular subtyping models for predicting lung cancer prognosis and immune microenvironment, and to screen key molecules driving BrM. Based on H1299 and PC9-BrM cells, <i>in vitro</i> experiments demonstrated the regulatory role and mechanism of targeting protein for Xklp2 (TPX2) in lung cancer BrM.</p><p><strong>Results: </strong>We identified 20 BrM-associated genes. Consensus clustering based on these genes stratified patients into two subtypes, with patients in Subtype 2 showing significantly worse overall survival (OS), progression-free survival (PFS), and disease-specific survival (DSS). Mechanistic analyses revealed marked activation of proliferation-related pathways in Subtype 2. TPX2 was identified as a critical mediator, with significantly elevated expression in BrM lesions compared with primary lung cancer lesions, and TPX2 overexpression correlated with poorer prognosis. Functional assays in H1299 and PC9-BrM cells demonstrated that <i>TPX2</i> knockdown markedly impaired proliferation, clonogenicity, migration, and invasion. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses and Western blotting validation further indicated that TPX2 likely promotes NSCLC-BrM by activating c-MYC and the epithelial-mesenchymal transition (EMT) process.</p><p><strong>Conclusions: </strong>Our study established a molecular classification system that effectively stratifies NSCLC-BrM patients and predicts survival. Moreover, TPX2 promotes NSCLC-BrM through c-MYC/EMT regulation, offering new insights for targeted therapeutic strategies.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":"38 5","pages":"606-623"},"PeriodicalIF":6.7000,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746056/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21147/j.issn.1000-9604.2026.05.08","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Brain metastasis (BrM) is a common complication of advanced lung cancer with extremely poor prognosis. This study aimed to establish a molecular classification system for stratifying non-small cell lung cancer (NSCLC)-BrM patients and predicting survival, and to identify key BrM-related molecules and elucidate their mechanisms as potential therapeutic targets.
Methods: We integrated single-cell and bulk transcriptomic data to construct molecular subtyping models for predicting lung cancer prognosis and immune microenvironment, and to screen key molecules driving BrM. Based on H1299 and PC9-BrM cells, in vitro experiments demonstrated the regulatory role and mechanism of targeting protein for Xklp2 (TPX2) in lung cancer BrM.
Results: We identified 20 BrM-associated genes. Consensus clustering based on these genes stratified patients into two subtypes, with patients in Subtype 2 showing significantly worse overall survival (OS), progression-free survival (PFS), and disease-specific survival (DSS). Mechanistic analyses revealed marked activation of proliferation-related pathways in Subtype 2. TPX2 was identified as a critical mediator, with significantly elevated expression in BrM lesions compared with primary lung cancer lesions, and TPX2 overexpression correlated with poorer prognosis. Functional assays in H1299 and PC9-BrM cells demonstrated that TPX2 knockdown markedly impaired proliferation, clonogenicity, migration, and invasion. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses and Western blotting validation further indicated that TPX2 likely promotes NSCLC-BrM by activating c-MYC and the epithelial-mesenchymal transition (EMT) process.
Conclusions: Our study established a molecular classification system that effectively stratifies NSCLC-BrM patients and predicts survival. Moreover, TPX2 promotes NSCLC-BrM through c-MYC/EMT regulation, offering new insights for targeted therapeutic strategies.
期刊介绍:
Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631) is published by AME Publishing Company in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013.
CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.